These findings align with former studies analyzing KIT, KRAS, and CDKN1B alterations in seminoma, along with their roles in the MAPK/ERK pathway, PI3K/AKT pathway, and cell cycle regulation [13,27,28,29,33,34,35]. The gene discussed is KRAS; the disease is seminoma.